Silodosin

Trade Name: 
Rapaflo
Manufacturer/Distributor: 
Watson Pharma
905-829-3566
Classification: 
Alpha-1 adrenergic blocker
ATC Class: 
G04CA04 - silodosin
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/01/11
Date Marketed in Canada (yyyy/mm/dd): 
2012/03/05
Presentation: 
Capsules: 4 mg. DIN: 02361663
Capsules: 8 mg. DIN: 02361671
Comments: 
For the treatment of signs and symptoms of benign prostatic hyperplasia.